Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Atavistik Bio, Inc
Dana-Farber Cancer Institute
AgonOx, Inc.
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Eli Lilly and Company
University of California, San Francisco
Dana-Farber Cancer Institute
Milton S. Hershey Medical Center
Eli Lilly and Company
Novartis
University Teaching Hospital Hall in Tirol
Promontory Therapeutics Inc.